Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 481

1.

Red flags in scleroderma.

Li Q, Sahhar J, Littlejohn G.

Aust Fam Physician. 2008 Oct;37(10):831-4. Review.

PMID:
19002303
2.

Systemic sclerosis/scleroderma: a treatable multisystem disease.

Hinchcliff M, Varga J.

Am Fam Physician. 2008 Oct 15;78(8):961-8.

4.

Clinical manifestations of systemic sclerosis.

Steen VD.

Semin Cutan Med Surg. 1998 Mar;17(1):48-54. Review.

PMID:
9512107
5.

[Initial visceral involvement with diffuse systemic scleroderma].

Gruschwitz MS, Steffan C, Albrecht HP, Hornstein OP.

Hautarzt. 1994 Nov;45(11):787-91. German.

PMID:
7822206
6.

[How to recognize scleroderma].

Francès C, Ayoub N, Barete S.

Rev Prat. 2002 Nov 1;52(17):1884-90. Review. French.

PMID:
12532864
7.

[Progressive systemic sclerosis].

Schramm A, Maas D.

Med Klin. 1979 Nov 16;74(46):1689-99. Review. German. No abstract available.

PMID:
392285
8.

[Myositis disclosing systemic scleroderma].

Leys D, Hatron PY, Parent M, Pasquier F, Krivosic I, Petit H.

Rev Neurol (Paris). 1984;140(11):670-2. French.

PMID:
6505497
9.

[The clinical spectrum of patients with anticentromere antibodies].

Insua Vilariño S, de la Hera Martínez M, Rodríguez-Valverde V, Merino Pérez J, Alonso Valdivieso JL, Ruiz T.

Rev Clin Esp. 1993 Apr;192(6):260-4. Spanish.

PMID:
8497719
10.

Raynaud phenomenon and the vascular disease in scleroderma.

Kahaleh MB.

Curr Opin Rheumatol. 2004 Nov;16(6):718-22. Review.

PMID:
15577610
11.

Clinical association of autoantibodies to fibrillarin with diffuse scleroderma and disseminated telangiectasia.

Kurzhals G, Meurer M, Krieg T, Reimer G.

J Am Acad Dermatol. 1990 Nov;23(5 Pt 1):832-6.

PMID:
2254467
12.

Treatment of complications associated with systemic sclerosis.

Moore SC, Desantis ER.

Am J Health Syst Pharm. 2008 Feb 15;65(4):315-21. doi: 10.2146/ajhp070024. Review.

PMID:
18238768
13.

[Systemic sclerosis].

Tamborrini G, Distler M, Distler O.

Med Monatsschr Pharm. 2008 May;31(5):162-70; quiz 171-2. Review. German.

PMID:
18552072
14.

Progressive systemic sclerosis in Auckland: a ten year review with emphasis on prognostic features.

Eason RJ, Tan PL, Gow PJ.

Aust N Z J Med. 1981 Dec;11(6):657-62.

PMID:
6949543
15.

Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients.

Medsger TA Jr, Masi AT, Rodnan GP, Benedek TG, Robinson H.

Ann Intern Med. 1971 Sep;75(3):369-76. No abstract available.

PMID:
4105464
16.

[When thinking to scleroderma?].

Cogan E.

Rev Med Brux. 2007 Sep;28(4):285-9. French.

PMID:
17958022
17.

[Systemic scleroderma].

Rommel A.

Sem Hop. 1984 Mar 1;60(10):710-24. Review. French.

PMID:
6322321
18.

Advances in palliative care for the patient with scleroderma.

Herrick AL.

Curr Opin Rheumatol. 1996 Nov;8(6):555-60. Review.

PMID:
9018459
19.

Scleroderma--clinical and pathological advances.

Denton CP, Black CM.

Best Pract Res Clin Rheumatol. 2004 Jun;18(3):271-90. Review.

PMID:
15158741
20.

Care of patients with scleroderma in the intensive care setting.

Farber HW, Simms RW, Lafyatis R.

J Intensive Care Med. 2010 Sep;25(5):247-58. doi: 10.1177/0885066610371181. Epub 2010 Jun 11. Review.

PMID:
20542965

Supplemental Content

Support Center